Inclusion criteria of study need clarification
- Tom Fahey (tom.fahey@bristol.ac.uk), senior lecturer in general practice,
- Alan Montgomery, MRC training fellow,
- Knut Schroeder, MRC training fellow
- Division of Primary Health Care, University of Bristol, Bristol BS8 2PR
- Epidemiology and Public Health, Newcastle General Hospital, Newcastle NE4 6BE
- Department of General Practice, Catholic University of Leuven, B 3000 Leuven, Belgium
- Department of Epidemiology, Scientific Institute of Public Health, B1050 Brussels
EDITOR—Wauters et al report on the diagnostic value of rectal bleeding in terms of subsequent development of colorectal cancer.1 We feel that this study requires clarification for several reasons.
Firstly, the authors do not report the pre-test probability of colorectal cancer in age specific categories in their population. The diagnostic value of a symptom such as rectal bleeding and the impact on post-test probability and subsequent referral threshold are maximised when the pre-test probability of the disease is known.2
Secondly, they fail to mention that less than half of patients with rectal bleeding have no other symptoms.3 More often it is associated with other bowel symptoms that have higher diagnostic value than rectal bleeding alone.4
Thirdly, the reported positive likelihood ratio of 68.3 “rules in” a diagnosis of colorectal cancer, irrespective of the pre-test probability of the disease.2 The reported specificity of 99.5% has the same effect of ruling in the target disorder of colorectal cancer. These findings imply that any patients attending their general practitioner with rectal bleeding need referral and further evaluation. Our own clinical experience and other community based studies of rectal bleeding indicate that such a high specificity and likelihood ratio is unlikely and may well be misleading. 4 5
Finally, the most likely explanation for the results relates to general practitioners underreporting rectal bleeding in the prospective arm of the study. Wauters et al chose “rectal bleeding as the reason …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012